Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2000
08/30/2000EP0831912A4 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
08/30/2000EP0831876A4 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
08/30/2000EP0828702B1 Process for resolving chiral acids with 1-aminoindan-2-ols
08/30/2000EP0821680B1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
08/30/2000EP0799198B1 Anti-inflammatory compounds
08/30/2000EP0787141B1 Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
08/30/2000EP0785714B1 Antimicrobial composition
08/30/2000EP0770083B1 PYRIDO[3,2,1-i,j][3,1]BENZOXAZINE DERIVATIVES
08/30/2000EP0765328B1 Pirydyl imidazole derivatives and processes for the preparation thereof
08/30/2000EP0749418B1 L-n6 -(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
08/30/2000EP0742789B1 Pharmaceutically active compounds and liposomes, and methods of use therof
08/30/2000EP0690843B1 Formyl- or cyano- substituted indole derivatives having dopaminergic activity
08/30/2000EP0642343B1 Acridine carboxamides for the treatment of cancer
08/30/2000EP0612246B1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
08/30/2000CN1265114A Method for large-scale production of Di (uridine 5'-tetraphosphate) and salts thereof
08/30/2000CN1265113A Prodn. method of avermectin compounds
08/30/2000CN1265112A Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
08/30/2000CN1265109A Thiazolobenzoheterocycles, prepn. and medicines containing same
08/30/2000CN1265108A 4-oxo-3,5-dihydro-4H-pyridazino [4,5-b]-indole-1-acetamide derivatives, their prepn. and their application in therapy
08/30/2000CN1265106A Compounds derived from thophene and benzothiophene, and related utilisation and compsn.
08/30/2000CN1265102A Benzothia (oxa) diazol derivatives and their use as endothelin-receptor antagonists
08/30/2000CN1265101A Crystalline dibentothiazepine derivatives and its use as antipsychotic agent
08/30/2000CN1265098A Heterocyclic derivatives which inhibit factor XA
08/30/2000CN1265097A Pyrrolidine carboxylic acid derivatives as endothelin antagonists
08/30/2000CN1265096A Hydrazine derivatives
08/30/2000CN1265091A Aminoethylphanoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithasis
08/30/2000CN1265039A Use of texaphyrin in prepn. of medicament for use in ocular diagnosis and therapy
08/30/2000CN1265037A Soya extract, process for its prepn. and pharmaceutical compsn.
08/30/2000CN1265035A Method for inhibiting bone resorption
08/30/2000CN1265034A Treatment of hepatic cirrhosis
08/30/2000CN1265033A Certain diarylimidaozle derivatives, new class of NPY speific ligands
08/30/2000CN1265032A Therapeutic and dietary compsns. containing essential fatty acids and bioactive disulphides
08/30/2000CN1265029A Pharmaceutical compsn. having two coating layers
08/30/2000CN1265010A Dehydration plant
08/30/2000CN1265007A Disinfectant compsn.
08/30/2000CN1264711A Derivative of lentinan monomer and its preparing process and application
08/30/2000CN1264708A Total safflower yellow and its preparing process and application
08/30/2000CN1264704A Novel spiro imidazoline compounds, their prepn. method and medicinal compsns. containing same
08/30/2000CN1264585A Exterior-applied Chinese-medicinal liniment for treating alopecia areata, seborrheic alopecia and bald
08/30/2000CN1264581A Medicine for reducing vaginal acidity and its usage
08/30/2000CN1264580A Application of tanshinone in preparing medicine for treating tumor
08/30/2000CN1264577A Face-care, skin protective compsns. containing succinic hydrochloric acid compound
08/30/2000CN1264575A Application of dimeric alpha-alkyl phenylethylene derivative as light stability ultraviolet filtering agent in cosmetics and medicinal preparation
08/30/2000CN1055927C Synthetizing and application of laevo-rotation ofloxacin analogue
08/30/2000CN1055926C New acronycine analogues, process for their prepn. and pharmaceutical compsns. containing them
08/30/2000CN1055924C Novel aminoalkyl benzoxazolinones and benzothizolinones and pharmaceutical compsns. and method for preparing same
08/30/2000CN1055922C Lactone compound and process of prodn. thereof
08/30/2000CN1055921C Derivative of vitamin D system which is modified in 20-position, prepn. of same and pharmaceutical made of same
08/30/2000CN1055920C Aklyl benzoylguanidines derivatives
08/30/2000CN1055919C Arylbenzoylguanidin
08/30/2000CN1055859C Application of stilbene compound and its derivative in prepn. of endothelium element antagonist agent
08/30/2000CN1055858C Medicine for toothache
08/30/2000CN1055855C Eexternal-use medicine for curing scars
08/30/2000CN1055835C Lianhuangsong pill and capsule and its prepn. method
08/30/2000CN1055827C Sustained-release matrices for dental application
08/29/2000US6111132 Compounds and methods for synthesis and therapy
08/29/2000US6111131 Beta, gamma-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound
08/29/2000US6111109 Cyclizing a 2-(2-alkyloxycarbonylphenyl)amino-)benzaldehyde by treating with a boron trifluoride; neutralization of the formed salt; amidation with an 2-n,n-dialkylaminoethylamine;antitumor and -carcinogenic
08/29/2000US6111095 Capped synthetic RNA, analogs, and aptamers
08/29/2000US6111094 Enhanced antisense modulation of ICAM-1
08/29/2000US6111086 Blocking agents for 2'-o position during rna synthesis; cleavable under mild acidic conditions leaving quality rna
08/29/2000US6111085 Carbamate-derivatized nucleosides and oligonucleosides
08/29/2000US6111084 Sialyl lewis mimetics produced by solid phase synthesis; antiinflammatory agents
08/29/2000US6111081 Lactoferrin variants and uses thereof
08/29/2000US6111074 Amino acid sequence of polypeptide from the uridine monophosphate kinase family; for screening bactericides and bacteriostats; for diagnosis and prophylaxis of infections
08/29/2000US6110974 Administering optically pure eutomer of adrenergic beta-2 agonist albuterol, while minimizing or eliminating side effects residing in the corresponding distomer
08/29/2000US6110973 Methods for treating obesity and weight gain using optically pure (-)-bupropion
08/29/2000US6110972 Methods and compositions for treating urinary incontinence using enantiomerically enriched (S)-tridihexethyl
08/29/2000US6110971 Fungicide composition comprising a benzoylphenylurea
08/29/2000US6110966 Triple action complex
08/29/2000US6110965 Useful for treating bacterial infections in humans and animals
08/29/2000US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer
08/29/2000US6110962 For treating insulin resistance, type ii diabetes, hyperglycemia, modulating insulin levels in mammals
08/29/2000US6110961 Phenoxathin derivatives as inhibitors of monoamine oxidase
08/29/2000US6110960 Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
08/29/2000US6110958 Pyrrole compounds having parasiticidal properties
08/29/2000US6110957 Antitumor agent treating cell proliferative disorders such as cancer, dyes, fungicides, bactericides
08/29/2000US6110954 Treatment
08/29/2000US6110953 A therapeutic drug mixture comprising a 1h-1,2,4-triazole with a chemotherapeutic agents can both reduce and suppress the growth of cancers, tumors and leukemia; synergistic effect
08/29/2000US6110952 Preventing or treating nasal congestion, otitis media and sinusitis without undesired side effects, also asthma, pain, migraine, substance abuse and addiction, gastrointestinal disorder, ulcer, stomach hyperacidity
08/29/2000US6110951 Thiazolidine derivatives for the treatment of hypertension
08/29/2000US6110948 Treating of malignant tumor, tuberculosis, diabetes, blood dyscrasia, endocrine disease, infectious disease, or acquired immunodeficiency syndrome
08/29/2000US6110947 An analgesic agent for treating stroke, abdominal pain; as antiinflammatory, diuretic, anesthetic or neuroprotective agents
08/29/2000US6110945 An antiinflammatory agent inhibiting the binding of integrins to their ligands; in the prophylaxis for treating immune or inflammatory disorders
08/29/2000US6110944 LTA4, hydrolase inhibitors
08/29/2000US6110942 Method for minimizing the uterotrophic effect of droloxifene
08/29/2000US6110941 Compounds analogous to thalidomide from the class comprising piperidine-2,6-diones
08/29/2000US6110940 Salts of an anti-migraine indole derivative
08/29/2000US6110939 As a substance p antagonists treating tachykinin-mediated disease, asthma, central nervous system disorder
08/29/2000US6110938 1-(arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics
08/29/2000US6110937 A sodium channel blocker treating as local anesthetics and in the treatment of cardiac arrhythmias
08/29/2000US6110936 A bactericide treating a bacterial infection in a warm blooded animal
08/29/2000US6110935 A promoter for n-methyl-d-aspartic acid (nmda) receptors, useful for such therapeutic purposes as facilitating the learning of behaviors, treating schizophrenia, memory impairment
08/29/2000US6110934 Substituted benzamide derivatives and their use as anticonvulsants
08/29/2000US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor
08/29/2000US6110932 Increase the level of endogenous growth hormone for the treatment and prevention of osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair, accelerating wound healing
08/29/2000US6110929 Immunomodulators which induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor and inhibit t-helper-type 2 immune response; for treatment of viral and neoplastic diseases
08/29/2000US6110928 Human or veterinary medicine
08/29/2000US6110927 Treatment of atrial fibrillation
08/29/2000US6110926 Storage stable aqueous solution of naloxone hydrochloride mixed with a polyhydric alcohol; for opioid addiction testing